Therefore, there has been considerable interest in targeting ACLY with anti-cancer drugs since many cancer cells rely on its activity in fatty acid metabolism, cholesterol biosynthesis, and protein acetylation and prenylation (Hatzivassiliou et al, 2005; Zaidi et al, 2012). This evidence concerns the gene ACLY and cancer.